Evidence map›Paper›PMID 29287234›Full record

ReviewCurrent opinion in chemical biology2018

Improving the discovery of secondary metabolite natural products using ion mobility-mass spectrometry.

Alexandra C Schrimpe-Rutledge, Stacy D Sherrod, John A McLean

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Natural Products Dereplication: Databases and Analytical Methods.Progress in the chemistry of organic natural products · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Alkaloids of the GenusMolecules (Basel, Switzerland) · 2021
    Review
  12. Review
  13. Mining and Biosynthesis of Bioactive Lanthipeptides From Microorganisms.Frontiers in bioengineering and biotechnology · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexandra C Schrimpe-RutledgeDepartment of Chemistry, Vanderbilt Institute of Chemical Biology, Center for Innovative Technology, Vanderbilt University, Nashville, TN 37235, USA.
Stacy D SherrodDepartment of Chemistry, Vanderbilt Institute of Chemical Biology, Center for Innovative Technology, Vanderbilt University, Nashville, TN 37235, USA; Vanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, TN 37235, USA.
John A McLeanDepartment of Chemistry, Vanderbilt Institute of Chemical Biology, Center for Innovative Technology, Vanderbilt University, Nashville, TN 37235, USA; Vanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, TN 37235, USA. Electronic address: john.a.mclean@vanderbilt.edu.

Funding

New Methodologies for Accelerating Natural Product DiscoveryR01GM092218 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, MCLEAN, JOHN ALAN · 2010 to 2018
$2.8M
NIGMS NIH HHS R01 GM092218
6 · The paper itself

Abstract

Secondary metabolite discovery requires an unbiased, comprehensive workflow to detect unknown unknowns for which little to no molecular knowledge exists. Untargeted mass spectrometry-based metabolomics is a powerful platform, particularly when coupled with ion mobility for high-throughput gas-phase separations to increase peak capacity and obtain gas-phase structural information. Ion mobility data are described by the amount of time an ion spends in the drift cell, which is directly related to an ion's collision cross section (CCS). The CCS parameter describes the size, shape, and charge of a molecule and can be used to characterize unknown metabolomic species. Here, we describe current and emerging applications of ion mobility-mass spectrometry for prioritization, discovery and structure elucidation, and spatial/temporal characterization.

Indexed as

Drug DiscoveryMetabolomicsBiological ProductsIon Mobility SpectrometryMass SpectrometryMolecular StructureWorkflowBiological Products

Identifiers

PMID29287234
PMCPMC5828964

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.